CAMBRIDGE, United Kingdom, Feb. 01, 2005 (PRIMEZONE) -- * Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Peter Ringrose to its Board * Dr Ringrose brings more than 30 years of pharmaceutical industry experience, with senior positions previously held at Bristol-Myers Squibb, Pfizer, Sandoz and Roche. * He will strengthen Astex's board as the Company prepares to take the first of its oncology drugs into the clinic during 2005
Full press release attached below: http://hugin.info/132636/R/978245/144487.pdf